Compare Stocks

Date Range: 

 thyssenkruppBB Seguridade ParticipaçõesStandard Life AberdeenOrient Overseas (International)Nissan Chemical
Price Information
Current Price$13.89$4.42$14.72$81.40$53.27
52 Week RangeHoldBuyHoldN/ABuy
Overall Score0.
Analysis Score0.
Community Score2.
Dividend Score0.
Ownership Score0.
Earnings & Valuation Score1.
Analyst Ratings
Consensus RecommendationHoldBuyHoldN/ABuy
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market Cap$8.65 billion$8.84 billion$8.03 billion$10.37 billion$7.72 billion
Average Volume25,143233,275807327711
Sales & Book Value
Annual Revenue$33.78 billion$1.22 billion$5.10 billion$6.88 billion$1.90 billion
Price / Sales0.267.261.571.514.06
CashflowN/A$0.37 per share$0.85 per share$5.98 per share$2.20 per share
Price / CashN/A12.0017.3813.6224.19
Book Value$18.31 per share$0.67 per share$14.11 per share$39.37 per share$11.61 per share
Price / Book0.766.601.042.074.59
Net Income$10.74 billion$1.69 billion$339.65 million$1.35 billion$283.18 million
Trailing P/E RatioN/A5.8914.8765.6530.09
Forward P/E Ratio13.6217.7311.1522.48
Net Margins31.76%128.23%N/AN/A14.72%
Return on Equity (ROE)-172.35%50.99%N/AN/A15.49%
Return on Assets (ROA)-16.32%26.87%N/AN/A12.17%
Annual PayoutN/A$0.13$0.71$0.42$0.65
Dividend YieldN/A2.94%4.82%0.52%1.22%
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/A71.72%33.87%34.76%
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity Ratio0.53%N/A0.14%0.19%N/A
Current Ratio2.26%N/A1.68%1.70%3.52%
Quick Ratio1.75%N/AN/A1.63%2.21%
Ownership Information
Institutional Ownership Percentage0.09%0.03%0.07%N/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Shares Outstanding622.53 million2.00 billion545.18 million127.44 million145.00 million
Next Earnings Date5/11/2021 (Estimated)5/13/2021 (Estimated)N/AN/A5/21/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
Nissan Chemical Corp. ADRNissan Chemical Corp. ADR - December 26 at 12:24 AM
NNCHY Nissan Chemical Corp ADRNNCHY Nissan Chemical Corp ADR - May 21 at 12:48 AM
Takeda Pharmaceutical Co. Ltd. ADRTakeda Pharmaceutical Co. Ltd. ADR - April 25 at 11:25 PM
AAA-ICDR®s Annual B2B Caseload Continues to Increase, Along with Level of Diversity in Arbitrator Roster & AppointmentsAAA-ICDR®'s Annual B2B Caseload Continues to Increase, Along with Level of Diversity in Arbitrator Roster & Appointments - February 29 at 8:08 AM
Nissan Chemical Corporation - ADRNissan Chemical Corporation - ADR - November 12 at 9:35 AM
Cerner's (CERN) AbleVets Buyout to Boost Federal ServicesCerner's (CERN) AbleVets Buyout to Boost Federal Services - October 22 at 11:31 AM
Heres Why You Should Retain Ecolab (ECL) Stock For NowHere's Why You Should Retain Ecolab (ECL) Stock For Now - October 14 at 10:49 PM
4/29/2021thyssenkruppCredit Suisse GroupInitiated Coverage
4/16/2021thyssenkruppDeutsche Bank AktiengesellschaftReiterated Rating
3/24/2021thyssenkruppMorgan StanleyReiterated Rating
1/18/2021thyssenkruppExane BNP ParibasUpgrade
12/2/2020thyssenkruppKepler Capital MarketsUpgrade
10/16/2020thyssenkruppJPMorgan Chase & Co.Reiterated Rating
5/15/2020thyssenkruppSociete GeneraleReiterated Rating
4/17/2020thyssenkruppCitigroupInitiated Coverage
5/22/2020BB Seguridade ParticipaçõesThe Goldman Sachs GroupInitiated Coverage
11/11/2020Standard Life AberdeenRoyal Bank of CanadaReiterated Rating
8/13/2020Standard Life AberdeenBerenberg BankReiterated Rating
9/14/2020Nissan ChemicalMizuhoDowngrade
3/5/2019Nissan ChemicalJefferies Financial GroupDowngrade
(Data available from 5/9/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.